Reports
Reports
Sale
The global fluorescence cell market size was valued at USD 724.6 million in 2023, driven by increased demand for new pharmaceuticals across the globe. The market is expected to grow at a CAGR of 6.3% during the forecast period of 2024-2032, with the values likely to rise from USD 770.2 million in 2024 to USD 1255.8 million by 2032.
Fluorescence cell imaging enables scientists to visualize and study cellular processes with exceptional detail and precision. This technology involves the use of fluorescent dyes and probes that emit light of specific wavelengths when excited by light of a different wavelength. With the help of this technique, researchers can study numerous cellular components, such as proteins, nucleic acids, and organelles, in real-time and with high sensitivity. Fluorescence cell imaging is widely used in research, diagnostics, and drug development.
The fluorescence cell market demand is driven by the increasing application of advanced imaging techniques in various research areas such as molecular biology, genetics, neuroscience, and drug discovery. Fluorescence cell imaging technique provides researchers with valuable insights into cellular dynamics, protein interactions, and disease mechanisms which helps them develop personalized treatments plans for patients in need.
The market growth can be attributed to the growing technical advancements in the microscopy field. In May 2023, the scientists from Max Planck Institute of Biochemistry (MPIB) and Ludwig-Maximilians-Universität (LMU), Munich, developed a technique to improve the fluorescence microscopy resolution. It employs a super-resolution technique called single-molecule localization microscopy (SMLM) to resolve sub cellular structures up to about ten nanometers in size by temporally separating their fluorescence emission.
The fluorescence cell market value is also growing with increasing application in the diagnosis domain. In diagnostics, fluorescence cell imaging helps in the identification and classification of specific biomarkers connected with diseases, helping with accurate diagnosis and personalized treatment decisions. In addition, with increasing integration of artificial intelligence into the medical research ecosystem, a portable AI-enhanced fluorescence microscope that offers real time target detection has also emerged in the market.
Market Breakup by Material Type
Market Breakup by Path Length
Market Breakup by End User
Market Breakup by Region
North America has been the largest fluorescence cell market share holder in recent years. With ongoing technical advancements, the region also boasts a well-structured research infrastructure to adapt to all the latest technologies.
Europe, on the other hand, has been a major contributor to the market value. The government bodies and authorities promote research activities. Recent mergers and acquisitions also foster significant innovation.
The Asia Pacific region has been experiencing significant transformation and is projected to witness expediated fluorescence cell market growth in the coming years. Acknowledging the academic talent and easy availability of resources, several influential MedTech companies are setting up new research labs and working on improving the prevailing system. Emerging economies like India are expected to expand with latest government initiatives. The government of India has launched a campaign to invest INR 5000 crore for developing new pharmaceuticals and drugs. Such initiatives will require improved imaging techniques and impact the fluorescence cell market directly.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Material Type |
|
Breakup by Path Length |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Fluorescence Cell Market Overview
3.1 Global Fluorescence Cell Market Historical Value (2017-2023)
3.2 Global Fluorescence Cell Market Forecast Value (2024-2032)
4 Global Fluorescence Cell Market Landscape
4.1 Global Fluorescence Cell Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Fluorescence Cell Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Path Length
5 Global Fluorescence Cell Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Fluorescence Cell Market Segmentation
6.1 Global Fluorescence Cell Market by Material Type
6.1.1 Market Overview
6.1.2 Optical Glass
6.1.3 Ultraviolet Quartz
6.1.4 Infrared Quartz
6.2 Global Fluorescence Cell Market by Path Length
6.2.1 Market Overview
6.2.2 1mm - 2mm
6.2.3 5mm - 10mm
6.2.4 10mm - 20mm
6.2.5 20mm and above
6.3 Global Fluorescence Cell Market by End User
6.3.1 Market Overview
6.3.2 Biotechnology Companies
6.3.3 Research Organizations
6.3.4 Academic Institutes
6.3.5 Others
6.4 Global Fluorescence Cell Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Fluorescence Cell Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Fluorescence Cell Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Fluorescence Cell Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Fluorescence Cell Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Fluorescence Cell Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Thermo Fisher Scientific Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 PerkinElmer Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 HORIBA, Ltd.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Agilent Technologies, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Bio-Rad Laboratories, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Danaher Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Oxford Instruments plc
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Bruker Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Tecan Group Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Hitachi, Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Carl Zeiss AG
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Hamamatsu Photonics K.K.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Merck KGaA
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Becton, Dickinson and Company (BD)
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Nikon Corporation
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Fluorescence Cell Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 724.6 million in 2023, driven by rising emphasis on developing new and effective drugs across the globe.
The market is anticipated to grow at a CAGR of 6.3% during the forecast period of 2024-2032, likely to reach a market value of USD 1255.8 million by 2032.
The market demand is driven by the increasing technical advancements in the imaging landscape that offer better and rapid results to the researchers, facilitating efficient drug development.
The current market trend revolves around rising convergence of artificial intelligence into research.
The material types in the market include optical glass, ultraviolet quartz, and infrared quartz.
The path lengths in the market are 1mm - 2mm, 5mm - 10mm, 10mm - 20mm, 20mm and above.
The end-users in the market are biotechnology companies, research organizations, and academic institutes, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are Thermo Fisher Scientific Inc., PerkinElmer Inc., HORIBA, Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Oxford Instruments plc, Bruker Corporation, Tecan Group Ltd., Hitachi, Ltd., Carl Zeiss AG, Hamamatsu Photonics K.K., Merck KGaA, Becton, Dickinson and Company (BD), and Nikon Corporation.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.